These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27180008)

  • 1. The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development.
    Hullmann J; Traynham CJ; Coleman RC; Koch WJ
    Pharmacol Res; 2016 Aug; 110():52-64. PubMed ID: 27180008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor kinases in normal and failing myocardium.
    Huang ZM; Gold JI; Koch WJ
    Front Biosci (Landmark Ed); 2011 Jun; 16(8):3047-60. PubMed ID: 21622221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Canonical and non-canonical actions of GRK5 in the heart".
    Traynham CJ; Hullmann J; Koch WJ
    J Mol Cell Cardiol; 2016 Mar; 92():196-202. PubMed ID: 26829117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing a structure-based docking approach to develop potent G protein-coupled receptor kinase (GRK) 2 and 5 inhibitors.
    Waldschmidt HV; Bouley R; Kirchhoff PD; Lee P; Tesmer JJG; Larsen SD
    Bioorg Med Chem Lett; 2018 May; 28(9):1507-1515. PubMed ID: 29627263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
    Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel roles for G protein-coupled receptor kinases in cardiac injury and repair.
    Kayki-Mutlu G; Koch WJ
    Biochem Soc Trans; 2023 Apr; 51(2):715-724. PubMed ID: 37013982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure.
    Agüero J; Almenar L; Montó F; Oliver E; Sánchez-Lázaro I; Vicente D; Martínez-Dolz L; D'Ocon P; Rueda J; Salvador A
    J Card Fail; 2012 Jan; 18(1):53-61. PubMed ID: 22196842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G protein-coupled receptor kinases as therapeutic targets in the heart.
    Pfleger J; Gresham K; Koch WJ
    Nat Rev Cardiol; 2019 Oct; 16(10):612-622. PubMed ID: 31186538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRK2 inhibition in heart failure: something old, something new.
    Lymperopoulos A; Rengo G; Koch WJ
    Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure.
    Laudette M; Formoso K; Lezoualc'h F
    Cells; 2021 Jan; 10(1):. PubMed ID: 33466800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans.
    Cohn HI; Xi Y; Pesant S; Harris DM; Hyslop T; Falkner B; Eckhart AD
    Hypertension; 2009 Jul; 54(1):71-6. PubMed ID: 19487588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRK2 in the heart: a GPCR kinase and beyond.
    Huang ZM; Gao E; Chuprun JK; Koch WJ
    Antioxid Redox Signal; 2014 Nov; 21(14):2032-43. PubMed ID: 24702056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets.
    Penela P; Murga C; Ribas C; Lafarga V; Mayor F
    Br J Pharmacol; 2010 Jun; 160(4):821-32. PubMed ID: 20590581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-protein receptor kinases 2, 5 and 6 redundantly modulate Smoothened-GATA transcriptional crosstalk in fetal mouse hearts.
    Franco A; Zhang L; Matkovich SJ; Kovacs A; Dorn GW
    J Mol Cell Cardiol; 2018 Aug; 121():60-68. PubMed ID: 29969579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.
    Liggett SB; Cresci S; Kelly RJ; Syed FM; Matkovich SJ; Hahn HS; Diwan A; Martini JS; Sparks L; Parekh RR; Spertus JA; Koch WJ; Kardia SL; Dorn GW
    Nat Med; 2008 May; 14(5):510-7. PubMed ID: 18425130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.
    Sato PY; Chuprun JK; Schwartz M; Koch WJ
    Physiol Rev; 2015 Apr; 95(2):377-404. PubMed ID: 25834229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy.
    Lieu M; Koch WJ
    Expert Opin Ther Targets; 2019 Mar; 23(3):201-214. PubMed ID: 30701991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial G protein-coupled receptor kinases: implications for heart failure therapy.
    Iaccarino G; Lefkowitz RJ; Koch WJ
    Proc Assoc Am Physicians; 1999; 111(5):399-405. PubMed ID: 10519160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. betaARKct: a therapeutic approach for improved adrenergic signaling and function in heart disease.
    Brinks H; Koch WJ
    J Cardiovasc Transl Res; 2010 Oct; 3(5):499-506. PubMed ID: 20623214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G Protein-Coupled Receptor Kinase 2 (GRK2) and 5 (GRK5) Exhibit Selective Phosphorylation of the Neurotensin Receptor in Vitro.
    Inagaki S; Ghirlando R; Vishnivetskiy SA; Homan KT; White JF; Tesmer JJ; Gurevich VV; Grisshammer R
    Biochemistry; 2015 Jul; 54(28):4320-9. PubMed ID: 26120872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.